Repligen Corp
XMUN:RGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Repligen Corp
XMUN:RGN
|
US |
|
Korian SA
F:KO2
|
FR |
|
Innocan Pharma Corp
F:IP40
|
IL |
|
A
|
Asia Sermkij Leasing PCL
SET:ASK
|
TH |
|
A
|
Acea SpA
SWB:DCA
|
IT |
|
ZTO Express (Cayman) Inc
F:ZTOA
|
CN |
|
G
|
Greenland Resources Inc
F:M0LY
|
CA |
|
Royalty Pharma PLC
NASDAQ:RPRX
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
F:TKDA
|
JP |
|
Shanghai Electric Group Co Ltd
F:USR
|
CN |
|
Shanghai Electric Group Co Ltd
OTC:SIELY
|
CN |
|
D
|
Dillard's Inc
XMUN:DL7A
|
US |
|
Sinopec Oilfield Service Corp
OTC:YZCFF
|
CN |
|
Resolution Minerals Ltd
OTC:RLMLF
|
AU |
|
T
|
Team Inc
F:T9CA
|
US |
|
A
|
Arobs Transilvania Software SA
XBSE:AROBS
|
RO |
|
P
|
Parsons Corp
F:59P
|
US |
|
Linedata Services SA
PAR:LIN
|
FR |
|
P
|
Perenti Ltd
XMUN:FWG
|
AU |
|
U
|
Universal Display Corp
F:UVD
|
US |
|
M
|
Major Cineplex Group PCL
SET:MAJOR
|
TH |
|
B
|
Beowulf Mining PLC
SWB:B4E
|
UK |
|
Severstal' PAO
MOEX:CHMF
|
RU |
|
R
|
Realtech AG
DUS:RTC
|
DE |
Wall St Price Targets
RGN Price Targets Summary
Repligen Corp
According to Wall Street analysts, the average 1-year price target for
RGN is 161.16 EUR with a low forecast of 127.49 EUR and a high forecast of 205.34 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGN's stock price target?
Price Target
161.16
EUR
According to Wall Street analysts, the average 1-year price target for
RGN is 161.16 EUR with a low forecast of 127.49 EUR and a high forecast of 205.34 EUR.
What is the Revenue forecast for Repligen Corp?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 8 years is 17%.
What is the Gross Profit forecast for Repligen Corp?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 8 years is 19%.
What is the Operating Income forecast for Repligen Corp?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 8 years is 31%.
What is the Pre-Tax Income forecast for Repligen Corp?
Projected CAGR
57%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 57%.
What is the Net Income forecast for Repligen Corp?
Projected CAGR
30%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 30%.